[1] [4] It is administered as a once-weekly subcutaneous injection and belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists
The LEAD-3 study found that liraglutide monotherapy reduced glycosylated hemoglobin (A1C), body weight, and blood pressure compared to glimepiride (36)
Although the main benefit that this nutrient provides is the loss of weight, there are other health benefits associated with it as well
Konopleva M, Zhao S, Jiang S, Snell V, Zhang X, Reed J, Andreeff M
I Found Out Im Pregnant While on a GLP-1: What Do I Do
Larger, well-designed clinical trials are needed to establish definitive recommendations, and current UK guidance does not support routine use